1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine

C63H82N24O9 — CID 52948387

IUPAC1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine
SMILES[H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)CNC(=O)[C@H](Cc2c[nH]cn2)NC1=O
InChIInChI=1S/C63H82N24O9/c64-61(65)72-20-8-17-44-54(90)81-45(18-9-21-73-62(66)67)56(92)87-50(26-38-30-70-33-78-38)53(89)77-32-52(88)80-51(27-39-31-71-34-79-39)60(96)84-47(23-35-11-2-1-3-12-35)57(93)82-46(19-10-22-74-63(68)69)55(91)85-49(25-37-29-76-43-16-7-5-14-41(37)43)59(95)86-48(58(94)83-44)24-36-28-75-42-15-6-4-13-40(36)42/h1-7,11-16,28-31,33-34,44-51,75-76H,8-10,17-27,32H2,(H,70,78)(H,71,79)(H,77,89)(H,80,88)(H,81,90)(H,82,93)(H,83,94)(H,84,96)(H,85,91)(H,86,95)(H,87,92)(H4,64,65,72)(H4,66,67,73)(H4,68,69,74)/t44-,45-,46-,47-,48-,49-,50-,51-/m0/s1
InChIKeyFXNPGVZFXZZLAI-HTSIWFDASA-N
MW1319.51 g/mol
LogP-2.59
Rot. Bonds22

About 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine

1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine (PubChem CID 52948387) has the molecular formula C63H82N24O9 and a molecular weight of 1319.51 g/mol. Its IUPAC name is 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine.

Molecular Properties

Compound Name1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine
PubChem CID52948387
Molecular FormulaC63H82N24O9
Molecular Weight1319.51 g/mol
Exact Mass1318.67
IUPAC Name1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine
SMILES[H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)CNC(=O)[C@H](Cc2c[nH]cn2)NC1=O
InChIInChI=1S/C63H82N24O9/c64-61(65)72-20-8-17-44-54(90)81-45(18-9-21-73-62(66)67)56(92)87-50(26-38-30-70-33-78-38)53(89)77-32-52(88)80-51(27-39-31-71-34-79-39)60(96)84-47(23-35-11-2-1-3-12-35)57(93)82-46(19-10-22-74-63(68)69)55(91)85-49(25-37-29-76-43-16-7-5-14-41(37)43)59(95)86-48(58(94)83-44)24-36-28-75-42-15-6-4-13-40(36)42/h1-7,11-16,28-31,33-34,44-51,75-76H,8-10,17-27,32H2,(H,70,78)(H,71,79)(H,77,89)(H,80,88)(H,81,90)(H,82,93)(H,83,94)(H,84,96)(H,85,91)(H,86,95)(H,87,92)(H4,64,65,72)(H4,66,67,73)(H4,68,69,74)/t44-,45-,46-,47-,48-,49-,50-,51-/m0/s1
InChIKeyFXNPGVZFXZZLAI-HTSIWFDASA-N
XLogP-2.59
TPSA536.54 Ų
H-Bond Donors22
H-Bond Acceptors14
Rotatable Bonds22
Heavy Atoms96
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001319.51
LogP ≤ 5-2.59
H-Bond Donors ≤ 522
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine?
The IUPAC name of 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine (CID 52948387) is 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine.
What is the SMILES notation for 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine?
The canonical SMILES for 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine is [H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN/C(N)=N/[H])NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)CNC(=O)[C@H](Cc2c[nH]cn2)NC1=O.
What is the InChIKey of 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine?
The InChIKey is FXNPGVZFXZZLAI-HTSIWFDASA-N. The full InChI is InChI=1S/C63H82N24O9/c64-61(65)72-20-8-17-44-54(90)81-45(18-9-21-73-62(66)67)56(92)87-50(26-38-30-70-33-78-38)53(89)77-32-52(88)80-51(27-39-31-71-34-79-39)60(96)84-47(23-35-11-2-1-3-12-35)57(93)82-46(19-10-22-74-63(68)69)55(91)85-49(25-37-29-76-43-16-7-5-14-41(37)43)59(95)86-48(58(94)83-44)24-36-28-75-42-15-6-4-13-40(36)42/h1-7,11-16,28-31,33-34,44-51,75-76H,8-10,17-27,32H2,(H,70,78)(H,71,79)(H,77,89)(H,80,88)(H,81,90)(H,82,93)(H,83,94)(H,84,96)(H,85,91)(H,86,95)(H,87,92)(H4,64,65,72)(H4,66,67,73)(H4,68,69,74)/t44-,45-,46-,47-,48-,49-,50-,51-/m0/s1.
What are the key properties of 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine?
1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine has a molecular weight of 1319.51 g/mol, XLogP of -2.59, 22 rotatable bonds, 22 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-[(2S,5S,8S,11S,14S,17S,23S,26S)-26-benzyl-11,14-bis(3-carbamimidamidopropyl)-17,23-bis(1H-imidazol-4-ylmethyl)-5,8-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27-nonaoxo-1,4,7,10,13,16,19,22,25-nonazacycloheptacos-2-yl]propyl]guanidine is sourced from PubChem (CID 52948387), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).